VANTOBRA

This brand name is authorized in Austria, Estonia, Spain, Croatia, Italy, Lithuania, Netherlands, United Kingdom

Active ingredients

The drug VANTOBRA contains one active pharmaceutical ingredient (API):

1 Tobramycin UNII VZ8RRZ51VK - TOBRAMYCIN

Tobramycin is an aminoglycoside antibiotic produced by Streptomyces tenebrarius. It acts primarily by disrupting protein synthesis leading to altered cell membrane permeability, progressive disruption of the cell envelope and eventual cell death. It is bactericidal at concentrations equal to or slightly greater than inhibitory concentrations. Read about Tobramycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01GB01	Tobramycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01G Aminoglycoside antibacterials → J01GB Other aminoglycosides
Discover more medicines within J01GB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1680971
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 181350001
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 329333
Country: IT	Agenzia del Farmaco	Identifier(s): 047635014
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1076029
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 135178